About the project

CRIMSON is a two year research project funded by the MS Society to understand how and why people with relapsing remitting multiple sclerosis choose to start disease modifying therapy treatment.

• In year one, through a series of focus groups and interviews with people with MS and clinicians we will explore what is important to people with MS when making decisions about which treatment to choose. With this information we will design a survey for people with MS presenting different scenarios including risks and benefits of different disease modifying treatments.
• In year two, the survey will be first piloted with a small number of people with MS, reviewed to take into considerations their views, and then sent to a large number of people with MS through the UKMS registry.

The results will help improve understanding of what risks and what benefits are important to people with MS when deciding on treatments and also it will support the design of information tools to improve decision-making about treatments.